Press coverage about Cutera (NASDAQ:CUTR) has been trending somewhat positive on Monday, AlphaOne Sentiment Analysis reports. The research group, a service of Accern, rates the sentiment of media coverage by reviewing more than 20 million news and blog sources in real time. AlphaOne ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Cutera earned a coverage optimism score of 0.11 on AlphaOne’s scale. AlphaOne also gave media stories about the medical device company an impact score of 25 out of 100, meaning that recent media coverage is very unlikely to have an effect on the stock’s share price in the next several days.
Here are some of the news articles that may have impacted AlphaOne Sentiment’s analysis:
- Contrasting Cutera (CUTR) & Lumenis (LMNS) (americanbankingnews.com)
- Cutera, Inc. (CUTR) Given Average Rating of “Strong Buy” by Analysts (americanbankingnews.com)
- Insider Selling: Cutera, Inc. (CUTR) EVP Sells 2,563 Shares of Stock (americanbankingnews.com)
- Noteworthy Monday Option Activity: CUTR, PKG, NEWR (stockoptionschannel.com)
A number of research analysts recently issued reports on CUTR shares. Sidoti reiterated a “buy” rating and issued a $30.00 price target (up previously from $27.00) on shares of Cutera in a research note on Saturday, June 3rd. TheStreet downgraded shares of Cutera from a “b-” rating to a “c” rating in a research note on Monday, May 1st. Finally, Zacks Investment Research downgraded shares of Cutera from a “hold” rating to a “sell” rating in a research note on Thursday, May 4th.
Shares of Cutera (NASDAQ:CUTR) traded up 6.85% during mid-day trading on Monday, hitting $24.95. 160,090 shares of the stock traded hands. The stock has a 50-day moving average of $21.67 and a 200 day moving average of $19.80. Cutera has a one year low of $10.42 and a one year high of $24.95. The stock has a market cap of $345.76 million, a PE ratio of 95.59 and a beta of 0.62.
Cutera (NASDAQ:CUTR) last announced its quarterly earnings data on Monday, May 1st. The medical device company reported ($0.07) earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.07). Cutera had a return on equity of 9.21% and a net margin of 2.89%. The firm had revenue of $29.30 million for the quarter, compared to analysts’ expectations of $29 million. During the same period last year, the business posted ($0.16) earnings per share. The firm’s revenue for the quarter was up 30.8% on a year-over-year basis. Equities analysts predict that Cutera will post $0.47 EPS for the current fiscal year.
In related news, EVP Miguel Pardos sold 5,000 shares of the firm’s stock in a transaction on Monday, April 3rd. The stock was sold at an average price of $20.73, for a total transaction of $103,650.00. Following the transaction, the executive vice president now directly owns 44,698 shares in the company, valued at $926,589.54. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Ronald J. Santilli sold 60,991 shares of the firm’s stock in a transaction on Monday, May 8th. The shares were sold at an average price of $19.99, for a total value of $1,219,210.09. Following the completion of the sale, the chief financial officer now owns 174,025 shares in the company, valued at $3,478,759.75. The disclosure for this sale can be found here. Insiders have sold 158,910 shares of company stock worth $3,324,504 over the last 90 days. 3.30% of the stock is currently owned by company insiders.
COPYRIGHT VIOLATION NOTICE: “Cutera (CUTR) Getting Somewhat Positive Press Coverage, AlphaOne Reports” was first published by BBNS and is owned by of BBNS. If you are reading this news story on another domain, it was copied illegally and republished in violation of US and international copyright law. The legal version of this news story can be accessed at https://baseballnewssource.com/markets/cutera-cutr-getting-somewhat-positive-press-coverage-alphaone-reports/1044077.html.
Cutera Company Profile
Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.
Receive News & Ratings for Cutera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera Inc. and related companies with our FREE daily email newsletter.